in silico


Also found in: Dictionary, Wikipedia.

in silico

adjective Computationally, as opposed to in vitro or in vivo.

in silico

(sĭ′lĭ-kō) [NL fm. L. silex, flint]
The mimicking or modeling of biological processes within computer hardware and software.

in silico

literally ‘in silicon’, i.e. ‘in the computer’; referring to analysis or experimentation carried out in a computer environment, rather than in the laboratory (IN VITRO), or in animals/plants/ microorganisms (IN VIVO). Given the increasing amount of genetic and molecular data available (from, for example, the HUMAN GENOME PROJECT), computational models could be used as virtual laboratories to test hypotheses rapidly and to prioritize empirical research. In silico technologies should facilitate advances in medical science, such as drug discovery and development.
References in periodicals archive ?
Open-source downloadable computational software and workflows, which will become available in an update of ICE this summer, will enable in silico predictions to be made using either data obtained from the ICE Data Integrator or provided by the user.
Contributed by pharmaceutical and other scientists from Europe, the US, and Argentina, the 18 chapters in this volume outline the theory, methods, challenges, and applications of in silico methods for drug discovery and design, discussing the theoretical framework and algorithms of computer-aided drug discovery and design, the range of validity, the strengths and limitations of each methodology, and applications to real-world drug discovery problems.
but the in silico world is not the one that we know and it intends to be a better one.
He details the databases and software available; programming guidelines, including a case study on the use of the C-It knowledge database (which he and his students developed) for in silico screening; experimental validation concepts and procedures; and an overview of additional potential applications of the approach in the field of stem cells and tissue regeneration.
Meanwhile, CLS plans to combine the in silico prediction technology with its proprietary large-scale in situ Hybridization (LisH) technique for applications in the drug target discovery and the safety evaluation of compounds while improving its technological capabilities.
KnowltAll offers a complete and fully integrated software environment for in silico ADME/-Fox prediction, a large predictor collection, and integrated tools for validation, batch prediction, database management, and customized reporting.
To increase processing power to these kinds of searches, as well as to bioinformatics operations and in silico experiments, biotech has adopted supercomputing, clustering, and grid computing.
Collins claims that in silico - computer programming in virtual laboratories - is one of the most used words of 2002 so far, although experts are swift to point out that it is still early days.
Unlike traditional high throughput trial and error experimental based discovery, Compugen utilizes a broad and continuously growing integrated infrastructure of proprietary scientific understandings and predictive platforms, algorithms, machine learning systems and other computational biology capabilities for the in silico (by computer) prediction and selection of product candidates, which are then advanced in its Pipeline Program to the pre-IND stage.
Contract notice: Delivery apparatus for extraction, processing, analysis and sterilization of biological samples for the purposes of invitro laboratory for evaluation of biological activity and toxicity laboratory for development and characterization of the pharmaceutical forms and the in silico design and laboratory extraction of natural products and synthetic of bioactive compounds in the science and technology park, which is implemented under the operational programme development of the competitiveness of the bulgarian economy 2007-2013 priority axis 1 development of economy based on knowledge and innovation according to the contract id number bg161po003-1.
In silico technologies in drug target identification and validation.
As many as one in three drugs fail in Phase I (healthy volunteer) clinical testing despite extensive pre-clinical screening of potential clinical candidates with a wide variety of in silico, in vitro, ex-vivo and animal models.